Top-tier investor syndicate led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures, Amgen Ventures, Amplitude Ventures and Air Street Capital. Gandeeva will use the funding to… Read More
VANOUVER & ALBERTA — Gowling WLG is pleased to announce that Dan Misutka has joined the firm as a partner in the Administrative Law Group. He will split his time between… Read More
Approval based on results from Phase 3 CROWN trial, showing LORVIQUA reduced risk of disease progression or death by 72% in newly diagnosed individuals compared to XALKORI® (crizotinib) NEW YORK… Read More
KENILWORTH, N.J. & MIAMI — Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced data from six preclinical studies demonstrating that molnupiravir,… Read More
VANCOUVER, B.C. — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has received… Read More
